ARTICLES BY CINDY DUBIN
-
Preformulation Reduces The Risk Of Drug Failure4/30/2012
By having formulators interact with discovery organizations at an earlier stage, the benefits of formulation and drug delivery technologies are being realized earlier. By Cindy Dubin, contributing editor
-
Pharma R&D Productivity Drops 70%3/8/2012
You have to spend money to make money. But, for the pharma industry, the return has been less than robust these last six years. According to a new study from consulting firm Oliver Wyman, the value generated by $1 invested in pharma R&D has fallen by more than 70%.
Cindy Dubin
Cindy Dubin has been reporting on the pharmaceutical industry since 2003, with a particular focus on executive decision making regarding formulation, delivery, development, and commercialization. She is the former Editor-in-Chief of both Pharmaceutical Formulation & Quality and Specialty Pharma magazines. She is now a freelance writer.